BR0214957A - Miméticos de superóxido dismutase para o tratamento de distúrbios e doenças oculares - Google Patents

Miméticos de superóxido dismutase para o tratamento de distúrbios e doenças oculares

Info

Publication number
BR0214957A
BR0214957A BR0214957-5A BR0214957A BR0214957A BR 0214957 A BR0214957 A BR 0214957A BR 0214957 A BR0214957 A BR 0214957A BR 0214957 A BR0214957 A BR 0214957A
Authority
BR
Brazil
Prior art keywords
treatment
diseases
superoxide dismutase
eye disorders
dismutase mimetics
Prior art date
Application number
BR0214957-5A
Other languages
English (en)
Inventor
Peter G Klimko
Robert J Collier Jr
Mark R Hellberg
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of BR0214957A publication Critical patent/BR0214957A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

"MIMéTICOS DE SUPERóXIDO DISMUTASE PARA O TRATAMENTO DE DISTúRBIOS E DOENçAS OCULARES". A presente invenção refere-se ao uso de miméticos de SOD particularmente mimético de SOD de complexos de pentaazaciclos de Mn(II), para o tratamento de AMD, DR, e edema retinal.
BR0214957-5A 2001-12-14 2002-12-06 Miméticos de superóxido dismutase para o tratamento de distúrbios e doenças oculares BR0214957A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34038901P 2001-12-14 2001-12-14
PCT/US2002/039037 WO2003051458A1 (en) 2001-12-14 2002-12-06 Superoxide dismutase mimics for the treatment of ocular disorders and diseases

Publications (1)

Publication Number Publication Date
BR0214957A true BR0214957A (pt) 2004-12-14

Family

ID=23333158

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0214957-5A BR0214957A (pt) 2001-12-14 2002-12-06 Miméticos de superóxido dismutase para o tratamento de distúrbios e doenças oculares

Country Status (19)

Country Link
US (2) US7759333B2 (pt)
EP (1) EP1463563B1 (pt)
JP (1) JP2005513063A (pt)
KR (1) KR100951606B1 (pt)
CN (2) CN1620325A (pt)
AT (1) ATE422944T1 (pt)
BR (1) BR0214957A (pt)
CA (1) CA2470721C (pt)
CY (1) CY1108983T1 (pt)
DE (1) DE60231246D1 (pt)
DK (1) DK1463563T3 (pt)
ES (1) ES2319399T3 (pt)
HK (1) HK1069785A1 (pt)
MX (1) MXPA04005601A (pt)
PL (1) PL210225B1 (pt)
PT (1) PT1463563E (pt)
SI (1) SI1463563T1 (pt)
WO (1) WO2003051458A1 (pt)
ZA (1) ZA200404435B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1463563T3 (da) * 2001-12-14 2009-04-20 Alcon Inc Superoxiddismutas-mimetika til behandling af öjenlidelser og -sygdomme
JP2007513948A (ja) * 2003-12-11 2007-05-31 アルコン，インコーポレイテッド 視神経損傷および網膜損傷の処置のためのスーパーオキシドジスムターゼ模倣物
US7803931B2 (en) 2004-02-12 2010-09-28 Archemix Corp. Aptamer therapeutics useful in the treatment of complement-related disorders
US8987245B2 (en) 2008-04-02 2015-03-24 Jonathan R. Brestoff Parker Composition and method for affecting obesity and related conditions
US8598150B1 (en) 2008-04-02 2013-12-03 Jonathan R. Brestoff Composition and method for affecting obesity and related conditions
CR20110389A (es) 2008-12-19 2011-07-13 Abbott Lab Compuestos y métodos de uso
EP2433640B1 (en) 2010-09-24 2020-01-15 OmniVision GmbH Composition comprising SOD, lutein and zeaxanthin
KR101214364B1 (ko) * 2011-02-15 2012-12-21 한림대학교 산학협력단 수퍼옥사이드 디스뮤테이즈 융합 단백질을 함유하는 안과 질환 예방 또는 치료용 약제학적 조성물
US9149483B2 (en) * 2011-09-26 2015-10-06 Galera Labs, Llc Methods for treatment of diseases
KR102531246B1 (ko) * 2021-12-23 2023-05-11 주식회사 제노포커스 수퍼옥시드 디스뮤타제 및 이의 건성 황반변성의 예방 또는 치료용 용도
WO2023224136A1 (ko) * 2022-05-16 2023-11-23 주식회사 제노포커스 수퍼옥시드 디스뮤타제 및 이의 당뇨망막병증 또는 포도막염의 예방 또는 치료용 용도

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5209926A (en) 1990-06-12 1993-05-11 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5124154A (en) * 1990-06-12 1992-06-23 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5994339A (en) 1993-10-15 1999-11-30 University Of Alabama At Birmingham Research Foundation Oxidant scavengers
US6127356A (en) 1993-10-15 2000-10-03 Duke University Oxidant scavengers
SE9402816D0 (sv) 1994-08-24 1994-08-24 Pharmacia Ab Method and meams for drug administration
US6214817B1 (en) * 1997-06-20 2001-04-10 Monsanto Company Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity
US6180620B1 (en) 1997-06-20 2001-01-30 G.D. Searle & Co. Analgesic methods using synthetic catalysts for the dismutation of superoxide radicals
JP2001521939A (ja) * 1997-11-03 2001-11-13 デューク・ユニバーシティー 置換されたポルフィリン類
US6291506B1 (en) 1998-08-04 2001-09-18 Wisconsin Alumni Research Foundation Method of reducing retinal ganglion cell degeneration
GB9817845D0 (en) 1998-08-17 1998-10-14 Glaxo Group Ltd Chemical compounds
WO2000023568A2 (en) 1998-10-06 2000-04-27 Albert Einstein College Of Medicine Of Yeshiva University Methods and compositions for decreasing mitochondrial overproduction of reactive oxygen species in cells
ATE291446T1 (de) 1999-05-27 2005-04-15 Monsanto Co Biomaterialien, modifiziert mit superoxid- dismutase imitatoren
DK1463563T3 (da) * 2001-12-14 2009-04-20 Alcon Inc Superoxiddismutas-mimetika til behandling af öjenlidelser og -sygdomme

Also Published As

Publication number Publication date
CN101092432A (zh) 2007-12-26
ZA200404435B (en) 2006-05-31
ATE422944T1 (de) 2009-03-15
DK1463563T3 (da) 2009-04-20
WO2003051458A1 (en) 2003-06-26
HK1069785A1 (en) 2005-06-03
SI1463563T1 (sl) 2009-06-30
US7759333B2 (en) 2010-07-20
ES2319399T3 (es) 2009-05-07
EP1463563B1 (en) 2009-02-18
KR20040063943A (ko) 2004-07-14
DE60231246D1 (de) 2009-04-02
US20050032768A1 (en) 2005-02-10
EP1463563A1 (en) 2004-10-06
CN1620325A (zh) 2005-05-25
PL369607A1 (en) 2005-05-02
AU2002351267B2 (en) 2007-04-05
PT1463563E (pt) 2009-03-19
CA2470721C (en) 2011-07-12
US20100204194A1 (en) 2010-08-12
KR100951606B1 (ko) 2010-04-09
CY1108983T1 (el) 2014-07-02
US8003635B2 (en) 2011-08-23
JP2005513063A (ja) 2005-05-12
PL210225B1 (pl) 2011-12-30
CA2470721A1 (en) 2003-06-26
AU2002351267A1 (en) 2003-06-30
MXPA04005601A (es) 2004-12-06

Similar Documents

Publication Publication Date Title
HK1069785A1 (en) Superoxide dismutase mimics for the treatment of ocular disorders and diseases
BR0317026A (pt) Mìmicos de superóxido dismutase para o tratamento de distúrbios e doenças oculares
WO2002085248A3 (en) Prostanoids augment ocular drug penetration
EA200400518A1 (ru) Способы лечения глазных неоваскулярных заболеваний
EA200701845A1 (ru) Рофлумиласт для лечения сахарного диабета
MXPA04011612A (es) Uso oftalmologico de roflumilasto para el tratamiento de enfermedades del ojo.
WO2006100677A3 (en) Device and method for pupil size modulation
WO2004004757A8 (en) Treatment for eye disorder
WO2001068053A3 (en) Methods and compositions for treating and preventing posterior segment ophthalmic disorders
MXPA04000124A (es) Composicion farmaceutica para la terapia de cistitis intersticial.
MXPA03009273A (es) AGENTE PARA EL TRATAMIENTO OFTaLMICO TOPICO DE LAS ENFERMEDADES INFLAMATORIAS OCULARES.
BR0017163A (pt) Derivados 5-hidróxi-indazol para tratamento do glaucoma
TR200101149T2 (tr) Dış retina bozukluklarının tedavisi.
UY28202A1 (es) Utilización de esteroides en el tratamiento de personas que sufren trastonos oculares.
ATE448779T1 (de) Methode zur behandlung trockener augen und uveitis
ATE487482T1 (de) Superoxid-dismutase-mimika zur behandlungvon augenstörungen und erkrankungen
BRPI0517972A (pt) ácido 5,6,7-triidroxiheptanóico e análogos para o tratamento de doenças oculares e doenças associadas com respostas hiperproliferativas e angiogênicas
DE60224667D1 (de) Perylenequinonen zur anwendung als sonosensitizer
AU2001267864A1 (en) Remedial agent for optic nerve disease and the like
BR0017168A (pt) Piranoindóis para tratamento de glaucoma
PT1178819E (pt) Glutationa-redutase para a terapia e profilaxia da sida
BRPI0417549A (pt) miméticos de superóxido dismutase para o tratamento de lesão de nervo óptico e retinal
MXPA04010816A (es) Acidos aminoalcanfosfonicos sustituidos para el tratamiento de dolor neuropatico, trastornos afectivos y de la atencion, esquizofrenia, tinitus, miopia y otros trastornos oculares.
ATE344054T1 (de) Behandlung von okularen neovaskularen erkrankungen
TW200600099A (en) Therapeutic or preventive agent for eye disease

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8 E 13 DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.

B15K Others concerning applications: alteration of classification

Ipc: A61K 31/555 (2006.01), A61P 27/02 (2006.01)